Estimates of chronic hepatitis B virus infection in Australia, 2000.
about
Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific RegionPrevalence of chronic hepatitis B virus infection before and after implementation of a hepatitis B vaccination program among children in NepalHepatocellular Carcinoma: Implications for Asia-Pacific Oncology NursesPost-arrival health screening in Karen refugees in Australia.Establishment of a surveillance system (utilising Midwifes Data Collection Systems) for monitoring the impact of hepatitis B vaccination on the population prevalence of chronic hepatitis B virus infection in Australia.Trends in all cause and viral liver disease-related hospitalizations in people with hepatitis B or C: a population-based linkage studyPrevalence of chronic hepatitis B in South Western Sydney: evaluation of the country of birth method using maternal seroprevalence data.Managing chronic hepatitis B: A qualitative study exploring the perspectives of people living with chronic hepatitis B in Australia.Current hepatitis B screening practices and clinical experience of reactivation in patients undergoing chemotherapy for solid tumors: a nationwide survey of medical oncologists.Distribution and risk factors of hepatitis B virus infection in the general population of Central IranBlood-borne viral and sexually transmissible infections among psychiatric populations: what are we doing about them?Hepatitis B and C virus infections and anti-tumor necrosis factor-alpha therapy: guidelines for clinical approach.Australian tertiary care outcomes of entecavir monotherapy in treatment naive patients with chronic hepatitis BHepatitis B virus reactivation following immunosuppressive therapy: guidelines for prevention and management.An overview of cancer and beliefs about the disease in Indigenous people of Australia, Canada, New Zealand and the US.Chronic hepatitis B infection in an Australian antenatal population: seroprevalence and opportunities for better outcomes.Management of chronic Hepatitis B infection in the remote primary health care setting: the search for a suitable guideline.Developing an evidence-based guideline for the management of exposure to hepatitis B at a Victorian tertiary hospital.Liver transplantation outcomes for Australian Aboriginal and Torres Strait Islanders.Mapping progress in chronic hepatitis B: geographic variation in prevalence, diagnosis, monitoring and treatment, 2013-15.Hepatitis B immunization for indigenous adults, Australia.The linguistic demography of Australians living with chronic hepatitis B.Hepatitis B status in migrants and refugees: increasing health burden in Western Australia.Rising incidence of hepatitis B-related hepatocellular carcinoma in South Australia: 1996-2010.Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or C.Cost-effectiveness analysis of entecavir versus lamivudine in the first-line treatment of Australian patients with chronic hepatitis B.Estimates and projections of hepatitis B-related hepatocellular carcinoma in Australia among people born in Asia-Pacific countries.Barriers to Accessing Testing and Treatment for Chronic Hepatitis B in Afghan, Rohingyan, and South Sudanese Populations in Australia.XWL-1-48 exerts antitumor activity via targeting topoisomerase II and enhancing degradation of Mdm2 in human hepatocellular carcinoma.Hepatitis B knowledge and associated factors among people with chronic hepatitis B.Infectivity of blood components from donors with occult hepatitis B infection - results from an Australian lookback programme.The burden of chronic hepatitis B virus infection in Australia, 2011.Challenges in managing patients in Australia with chronic hepatitis B: the General Practitioners' perspective.Country of birth and other factors associated with hepatitis B prevalence in a population with high levels of immigration.Isolated core antibody hepatitis B in sub-Saharan African immigrants.Knowledge about hepatitis and previous exposure to hepatitis viruses in immigrants and refugees from the Mekong Region.Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004.Trends in transfusion-transmissible infections among Australian blood donors from 2005 to 2010.Liver cancer and hepatitis B and C in New South Wales, 1990-2002: a linkage study.Use of biological disease-modifying anti-rheumatic drugs in patients with concurrent rheumatic disease and hepatitis B.
P2860
Q26750444-AF48A74A-2EB2-4FD4-B475-5DD63C6AB2F0Q27303069-89724DCD-2B37-4DD8-82A5-B63879866FDAQ30234460-E373617C-6EFD-4D82-B5AC-F35BCB0428BDQ31064280-17931AEE-95F1-4F78-9597-A70D315BE5B8Q31160446-A0905F43-621F-4C11-8962-149C5885206DQ33801743-B5E5A26A-915B-4B90-997A-0202F0C80D8EQ33813930-6A49E915-98DA-421B-81FD-347429D37342Q33836341-D6F69521-343D-4127-9113-8121AE96C734Q34974883-4F2E18EE-9DBF-44F3-8049-405A3F8B870BQ35875255-A82D168B-AB15-462E-89CB-381114D9696AQ36259545-BE011084-AAC8-4222-B304-C23CA2AE1099Q36566911-0638CD3B-EF11-4970-AF94-5268D1485AB4Q36615961-EA473E19-014F-44CC-B43E-E00CB4A2568AQ36951280-46D0780C-02FA-4BA8-A489-3BF952B0FA19Q37469327-C1E9125D-555A-4028-BDC6-052D72EDD3CFQ37564617-0F9B4719-DC37-4273-8508-FBBB9FC9E119Q37857896-7108B4E4-97B7-4B8F-A7ED-A581BCD6B3E0Q38148796-BA58EA8D-889B-4353-AF89-74819E8ACFAEQ38206177-D0E895FC-6145-421E-BE75-B5BA6EA47D7EQ38677134-2447A138-ACC0-45F4-90E2-097CFA879A25Q39207259-8B7097EA-30AE-4375-9A25-C4A3AFEB219FQ39225571-5C94366E-1529-4582-AE17-E5C6D7DBD570Q39668495-54B254B4-8365-4542-9602-0255FE8866BDQ39808711-137E945D-B13C-4962-AE14-2275270A788BQ39984667-29580598-4F4D-4245-9375-7DBA18E45D9EQ40140066-DC8E8F0D-D833-48F6-A6ED-ED41B6A673B5Q40197931-4829BD74-D0BE-4FD3-A8D0-13C0577D48BCQ40359328-1C1E63F2-C44E-4D3D-94A2-39F06B1D25D6Q41563902-65F13480-0E26-42A1-91CD-578C93C0CC80Q41653346-71ED303D-EF72-4602-8DF1-67546E9BA7AFQ41734031-2DEB4A17-9005-4D5C-BF15-10E8AB18C6A9Q42245674-0A635F9F-8B7D-4D80-BA2D-4C2171707B4EQ42265055-3BF1AE72-3876-4990-804A-534C18448429Q42265206-A8AFFE68-15F5-4E75-AA6A-9D7B328693B0Q42980246-E6AB15C0-0577-49A8-A6AC-9FAF6B1490A1Q42991433-143A660A-B088-47B1-927C-11809718114CQ43036225-C9B6053E-DD3B-4100-8684-330F5DBDCAFAQ43406238-BE7C3FD3-7D11-49AD-B964-3B51AF36403BQ43948092-C3BF8D53-D285-455A-ACA7-FEAB6CCF1FB5Q44464843-0C2F9056-A3CE-4E0A-BA64-A9D52D015642
P2860
Estimates of chronic hepatitis B virus infection in Australia, 2000.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Estimates of chronic hepatitis B virus infection in Australia, 2000.
@en
Estimates of chronic hepatitis B virus infection in Australia, 2000.
@nl
type
label
Estimates of chronic hepatitis B virus infection in Australia, 2000.
@en
Estimates of chronic hepatitis B virus infection in Australia, 2000.
@nl
prefLabel
Estimates of chronic hepatitis B virus infection in Australia, 2000.
@en
Estimates of chronic hepatitis B virus infection in Australia, 2000.
@nl
P2093
P2860
P50
P1476
Estimates of chronic hepatitis B virus infection in Australia, 2000
@en
P2093
Gregory J Dore
Gwendolyn L Gilbert
John M Kaldor
P2860
P304
P356
10.1111/J.1467-842X.2004.TB00697.X
P577
2004-06-01T00:00:00Z